Keywords
Coronary Disease ×
Show more Keywords
Table of contents
  1. 1. Clinical Trial
  2. 2. Routine Documentation
  3. 3. Registry/Cohort Study
  4. 4. Quality Assurance
  5. 5. Data Standard
  6. 6. Patient-Reported Outcome
  7. 7. Medical Specialty
Selected data models

You must log in to select data models for download or further analysis.

139 Search results.

Persönliches Interview SHIP-Trend-1 Herz-Kreislauf-Erkrankungen

- 2/13/21 - 1 form, 1 itemgroup, 5 items, 1 language
Itemgroup: Herz-Kreislauf-Erkrankungen
Herz-Kreislauf-Erkrankungen form of SHIP Study (Study of Health in Pomerania), conducted by the University Medicine of Greifswald. SHIP unique domain name TREND.TREND1.INT.KHK.KHK. ODM derived from https://www.fvcm.med.uni-greifswald.de/dd_service/data_use_explore.php. Further information: http://www2.medizin.uni-greifswald.de/cm/fv/ship.html. Publication granted by Prof. Völzke. Reference: Völzke H, et al. Cohort profile: the study of health in Pomerania. Int J Epidemiol. 2011;40(2):294-307. PMID: 20167617

Eligibility Coronary Artery Disease NCT00233792

- 10/6/20 - 1 form, 2 itemgroups, 13 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
FIM-BR - First-in-Man Study (Brazil Part) With Sirolimus-Coated BX VELOCITY Stent; ODM derived from: https://clinicaltrials.gov/show/NCT00233792

Collaborative Research Center | Transregio 240 (Sonderforschungsbereich Transregio 240) - Coronary heart disease (Koronare Herzerkrankung)

- 10/1/20 - 1 form, 6 itemgroups, 26 items, 1 language
Itemgroups: Patient-ID, Diagnostic analysis: cardiac symptoms, Diagnostic analysis: severity, Ischemia diagnostic procedure, Course of treatment: Intervention, Medication during transport to hospital
A central patient cohort within the interdisciplinary Collaborative Research Center / Transregio 240 aims to examine the role and function of platelets in different vascular diseases. In this questionnaire specific items on coronary heart disease patients are collected.

Liver imaging GSK study Chronic Coronary Heart Disease NCT00799903

- 6/17/20 - 1 form, 11 itemgroups, 60 items, 1 language
Itemgroups: Date of hepatic or liver imaging test, method used for imaging test, images technically adequate, liver size, liver texture, diffuse and/or geographic fatty infiltrate of the liver, Ascites present, Focal Hepatic Lesions characterisable, Gallstones or gallbladder lesions, Biliary ductal lesions, Portal/Hepatic vein abnormalities
Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Liver imaging - Repeating form (Unscheduled/Dynamic visit)

Gene Expression Test for Coronary Artery Disease Diagnosis NCT01594411 - Eligibility Criteria

- 7/7/19 - 1 form, 2 itemgroups, 9 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Primary Care Providers Use of a Gene Expression Test in Coronary Artery Disease Diagnosis; ODM derived from: https://clinicaltrials.gov/show/NCT01594411 This is a prospective, multi-center study examining the clinical impact of the Corus CAD (Age/Sex/Gene Expression score - ASGES) assay in approximately 250 evaluable subjects with no history of obstructive coronary artery disease who now present with chest pain or anginal-equivalent symptoms to a primary care physician (PCP) for evaluation.

Eligibility Coronary Heart Disease NCT02509013

- 3/12/19 - 1 form, 2 itemgroups, 14 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Prevalence of Chronic Kidney Disease and Its Association With Clinical Outcome in Patients With Coronary Heart Disease; ODM derived from: https://clinicaltrials.gov/show/NCT02509013

Eligibility Coronary Heart Disease NCT02435797

- 3/12/19 - 1 form, 2 itemgroups, 16 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Effect of Nicorandil for the Patients of Acute ST Segment Elevation Myocardial Infarction; ODM derived from: https://clinicaltrials.gov/show/NCT02435797

Eligibility Coronary Heart Disease NCT02389153

- 3/12/19 - 1 form, 2 itemgroups, 18 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Feasability of Collaborative Care in the Secondary Prevention of Coronary Heart Disease; ODM derived from: https://clinicaltrials.gov/show/NCT02389153

Eligibility Coronary Heart Disease NCT02044250

- 3/12/19 - 1 form, 2 itemgroups, 16 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- EXtended Antiplatelet Monotherapy (HOST-EXAM); ODM derived from: https://clinicaltrials.gov/show/NCT02044250

Eligibility Coronary Heart Disease NCT01735656

- 3/12/19 - 1 form, 2 itemgroups, 18 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Comparison of Double Kissing Culotte Stenting With Double Kissing Crush Stenting for True Bifurcation Lesions; ODM derived from: https://clinicaltrials.gov/show/NCT01735656

Eligibility Multiple Conditions NCT01597882

- 1/17/19 - 1 form, 2 itemgroups, 10 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Improving Monitoring of Patients Receiving Case Management; ODM derived from: https://clinicaltrials.gov/show/NCT01597882

Eligibility Coronary Heart Disease NCT02045134

- 1/15/19 - 1 form, 2 itemgroups, 10 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Supplementation With Polyphenol-Rich Foods and Atrial Fibrillation After a Cardiac Surgery; ODM derived from: https://clinicaltrials.gov/show/NCT02045134